Results

1–3 of 3 results for John A. Wells

Post Hoc Analyses of Responder Status in Phase 3 Studies of Ciliary Neurotrophic Factor–Producing Revakinagene Taroretcel in People With Macular Telangiectasia Type 2
John A. Wells, MD, FACS
Updates from the Field
2024
Protocol T Extension Results
John A. Wells, MD, FACS
Updates from the Field
2019
Diabetic Retinopathy Part II Take-Home Panel
John A. Wells, MD, FACS
Annual Meeting Talks